SPRB Stock Analysis: Buy, Sell, or Hold?
SPRB - Spruce Biosciences, Inc. Common Stock
$48.65
-1.42 (-2.84%)
▼
5d:
-6.17%
30d:
+3.23%
90d:
-23.54%
HOLD
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 13, 2026
30d
Get Alerted When SPRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SPRB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SPRB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$125.54
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$77.95
37.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SPRB is currently trading at $48.65, which is considered oversold relative to its 30-day fair value range of $48.97 to $53.53. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.1) compared to its historical average (18.1). Remarkably, the market is currently pricing in an annual earnings decline of 17.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SPRB is in a strong downtrend. Immediate support is located at $46.70, while resistance sits at $54.32.
Market Sentiment: SPRB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $149.71 (+199.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SPRB is in a strong downtrend. Immediate support is located at $46.70, while resistance sits at $54.32.
Market Sentiment: SPRB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $149.71 (+199.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$48.97 -
$53.53
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 199.0% below Wall St target ($149.71)
- CAUTION: 5-day price weakness (-6.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$48.97 -
$53.53
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$46.70
Resistance Level
$54.32
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.12
Wall Street Target
$149.71
(+199.0%)
Revenue Growth (YoY)
-75.9%
Valuation Discount vs History
-17.6% cheaper
PE vs Historical
10.1 vs 18.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-17.6%
(market-implied from PE analysis)
1-Year Target
$45.06
(-10%)
2-Year Target
$40.56
(-19%)
3-Year Target
$36.50
(-27%)
3-Yr Target (if PE normalizes)
(PE: 10→18)
$65.31
(+30%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.1 to 18.1
Stabilization Target:
$89.60
(+78.9%)
PE Expansion Potential:
+78.9%
Share & Embed Analysis
Last updated: July 13, 2026 12:43 PM ET
Data refreshes hourly during market hours. Next update: 1:43 PM
Data refreshes hourly during market hours. Next update: 1:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SPRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 61 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 65 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 63 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 59 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 50 HOLD |
